DK

C/O Chest Pain, Sweating, associated with generalized weakness for last 1 day prior to admission.Diagnosis – CAD/ACS/ACUTE AWMI (LP)/SEVERE LV SYSTOLIC DYSFUNCTION/ LVEF=15%/MODERATE MR/MILD TR/MILD PAH/ECG- Acute Anterior Wall MI. 

Left Main: Ostial 95% disease.LAD: Proximal 90% disease flowed by 99% disease.D1& D2: Normal.LCX: Non-Dominant, Normal.OM1 & OM2: Normal.RCA: Dominant, Proximal 50-60% disease, Mid 60-70% Tandem lesion.PLV/PDA: Normal. 

Left Main: Ostial 95% disease.LAD: Proximal 90% disease flowed by 99% disease.D1& D2: Normal.LCX: Non-Dominant, Normal.OM1 & OM2: Normal.RCA: Dominant, Proximal 50-60% disease, Mid 60-70% Tandem lesion. PLV/PDA: Normal.  

Left Coronary Artery was engaged with JL 3.5, 7F guide catheter. A 0.014” SION BLUE wire was used to cross the Left Main to LAD lesion. Pre dilation done with SC Sapphire Balloon 2.75 X10 mm @ 10 atmosphere. Drug Eluting Stent XIENCE XPEDITION LL 3.5 X 38 mm deployed in Left Main to Proximal LAD @ 10 atmosphere. Post dilation done with NC Sapphire Balloon 4.5 X 8 mm @ 10 atmosphere. GP IIb IIIa inhibitor was used during the procedure. Excellent result with TIMI III flow. Successful PTCA with stenting to Left Main to LAD. 
LEFT MAIN TO LAD (CTO) &.pptx

Percutaneous intervention with stent implantation for LMCA disease has become a standard procedure in contemporary practice with safety, expedited recovery, and durability. Precise selection of the strategy aided by intra coronary imaging, functional evaluation, and mechanical support when needed have improved the immediate and long-term results in this high risk intervention. It is however important to have a team approach and operator expertise before embarking on LMCA interventions